Consideration of the interaction of anti-diabetes agents
Haruta, Y.; Nishihara, S.; Sendo, T.
Nihon Rinsho. Japanese Journal of Clinical Medicine 73(3): 474-478
2015
ISSN/ISBN: 0047-1852 PMID: 25812376 Document Number: 684425
While taking anti-diabetes agents, in combination with drugs that attenuate the hypoglycemic action or drug, or that enhance the hypoglycemic action, it is necessary to pay attention to hypoglycemia and fluctuations in blood glucose levels. Furthermore, a coadministration of two or more anti-diabetes agents including newly coming drugs, especially used in combination with insulin formulations or insulin secretagogues should be closely monitored and may need to reduce the dose.
Document emailed within 1 workday
Related Documents
Labro, M.T. 1995: Interaction between anti-infective agents and phagocytes Presse Medicale 24(21): 992-998Lutsevich, A.N.; Bender, K.I.; Kupchikov, V.V. 1992: The pharmacological effect of nonsteroid anti-inflammatory agents and their interaction with blood plasma proteins Eksperimental'naia i Klinicheskaia Farmakologiia 55(2): 68-74
Capriotti, T. 2005: Type 2 diabetes epidemic increases use of oral anti-diabetic agents Medsurg Nursing: Official Journal of the Academy of Medical-Surgical Nurses 14(5): 341-347
Lumholtz, I.B. 1981: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 16. (3). Anti-arrhythmia agents with action on ventricular arrhythmias Sygeplejersken 81(2): 15
Takemoto, T.; Yanai, H. 1988: Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; problems on standardization of the appropriate time for the withdrawal of anti-ulcer agents Nihon Rinsho. Japanese Journal of Clinical Medicine 46(1): 133-139
Mekenyan, O.; Peitchev, D.; Bonchev, D.; Trinajstić, N.; Bangov, I. 1986: Modelling the interaction of small organic molecules with biomacromolecules. I. Interaction of substituted pyridines with anti-3-azopyridine antibody Arzneimittel-Forschung 36(2): 176-183
Andriole, V.T.; Ryan, J.L. 1982: An approach to formulary consideration of antimicrobial agents: the tetracyclines Hospital Formulary 17(7): 965-968
Bozzay, J.; Békefi, E.; Dávid, A.; Rusznák, I. 1983: Data for the modeling of drug-receptor interaction, taking into consideration additives or combined active ingredients in the formulation Acta Pharmaceutica Hungarica 53(3): 97-105
Fernández-Viadero, C.; Verduga, R.; Soto, J.; Alsar, M.J. 1993: The use of topical non-steroidal anti-inflammatory agents in elderly patients taking oral anticoagulation agents Medicina Clinica 100(5): 196-197
Lown, J.W. 1988: Lexitropsins: rational design of DNA sequence reading agents as novel anti-cancer agents and potential cellular probes Anti-Cancer Drug Design 3(1): 25-40
Sato, N.; Suzuki, H.; Hayashi, H.; Shibasaki, S.; Sugano, T.; Maebashi, K.; Kurosawa, T.; Shiomi, M.; Ogata, H. 2008: New concept and a theoretical consideration of the mechanism-based pharmacokinetics/ pharmacodynamics (PK/PD) modeling for antimicrobial agents Japanese Journal of Antibiotics 61(5): 314-338
Lumholtz, I.B. 1980: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 14. Digitalis glycosides Sygeplejersken 80(50): 13
Chimirri, A.; Grasso, S.; Montforte, A.M.; Monforte, P.; Zappalà, M. 1994: Anti-HIV agents. III. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]imidazo[4,5-b]pyridines Farmaco 49(5): 345-348
Chimirri, A.; Grasso, S.; Monforte, A.M.; Monforte, P.; Rao, A.; Zappalà, M.; Bruno, G.; Nicolò, F.; Scopelliti, R. 1997: Anti-HIV agents. V. Synthesis, structure and in vitro anti-HIV activity of novel 1H,3H-naphtho[2',3':4,5]imidazo[1,2-c]thiazoles Farmaco 52(11): 673-677
Tian, S.L.; Zhao, S.W.; Zhu, A.T.; Fang, Y.; Li, K.Q. 1993: Studies on anti-tumor agents. I: Synthesis and anti-cancer activity of amino acid derivatives of norcantharidin Yao Xue Xue Bao 28(11): 870-875
Kawai, K.; Shiojiri, H.; Fukushima, H.; Nozawa, Y.; Hasegawa, J.; Nozaki, M.; Tsurumi, K.; Fujimura, H. 1984: The effect of clidanac, a potent anti-inflammatory drug, on mitochondrial respiration: a consideration on the uncoupling activity of optical enantiomers Research Communications in Chemical Pathology and Pharmacology 45(3): 399-406
Lü, M.; Wang, T.-y.; Tian, X.-x.; Shi, X.-h.; Fan, G.-w.; Zhang, Y.; Zhu, Y. 2015: Interaction of anti-thrombotic and anti-inflammatory activities of commonly used traditional Chinese medicine for promoting blood circulation and removing blood stasis revealed by network pharmacology analysis Yao Xue Xue Bao 50(9): 1135-1141
Materson, B.J.; Reda, D.J.; Cushman, W.C.; Henderson, W.G. 1995: Results of combination anti-hypertensive therapy after failure of each of the components. Department of Veterans Affairs Cooperative Study Group on Anti-hypertensive Agents Journal of human hypertension 9(10): 791-796
Tuna, J.L. 1992: Classification of anti-arrhythmia drugs and their mechanism of action. Iatrogeny of anti-arrhythmia agents Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(4): 385-386
Horsmans, Y.; Larrey, D.; Pessayre, D.; Benhamou, J.P. 1990: Hepatotoxicity of antimicrobial agents. II: Urinary antiseptics, antitubercular agents, antiparasitic agents, antifungal agents, antiviral agents Gastroenterologie Clinique et Biologique 14(12): 919-924